K Thorborg1, M Tijssen2, B Habets2, E M Bartels3, E M Roos4, J Kemp5, K M Crossley6, P Hölmich1. 1. Sports Orthopedic Research Centre-Copenhagen, Arthroscopic Centre Amager, Copenhagen University Hospital, Copenhagen, Denmark. 2. Sports Medical Centre Papendal, Arnhem, The Netherlands. 3. The Parker Institute, Copenhagen University Hospital, Bispebjerg and Frederiksberg, Copenhagen, Denmark. 4. Institute of Sports Science and Clinical Biomechanics, University of Southern Denmark, Odense, Denmark. 5. Australian Centre for Research into Injury in Sport and its Prevention (ACRISP), Federation University Australia, Ballarat, Australia. 6. School of Health and Rehabilitation Science, The University of Queensland, Brisbane, Australia.
Abstract
BACKGROUND/AIM: To recommend Patient-Reported Outcome (PRO) questionnaires to measure hip and groin disability in young-aged to middle-aged adults. METHODS: A systematic review was performed in June 2014. The methodological quality of the studies included was determined using the COnsensus-based Standards for the selection of health Measurement INstruments list (COSMIN) together with standardised evaluations of measurement properties of each PRO. RESULTS: Twenty studies were included. Nine different questionnaires for patients with hip disability, and one for hip and groin disability, were identified. Hip And Groin Outcome Score (HAGOS), Hip Outcome Score (HOS), International Hip Outcome Tool-12 (IHOT-12) and IHOT-33 were the most thoroughly investigated PROs and studies including these PROs reported key aspects of the COSMIN checklist. HAGOS and IHOT-12 were based on studies with the least ratings of poor study methodology (23% and 31%, respectively), whereas IHOT-33 and HOS had a somewhat larger distribution (46%). These PROs all contain adequate measurement qualities for content validity (except HOS), test-retest reliability, construct validity, responsiveness and interpretability. No information or poor quality rating on methodological aspects made it impossible to fully evaluate the remaining PROs at present. CONCLUSIONS: HAGOS, HOS, IHOT-12 and IHOT-33 can be recommended for assessment of young-aged to middle-aged adults with pain related to the hip joint, undergoing non-surgical treatment or hip arthroscopy. At present, HAGOS is the only PRO also aimed for young-aged to middle-aged adults presenting with groin pain and is recommended for use in this population. TRIAL REGISTRATION NUMBER: CRD42014009995. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
BACKGROUND/AIM: To recommend Patient-Reported Outcome (PRO) questionnaires to measure hip and groin disability in young-aged to middle-aged adults. METHODS: A systematic review was performed in June 2014. The methodological quality of the studies included was determined using the COnsensus-based Standards for the selection of health Measurement INstruments list (COSMIN) together with standardised evaluations of measurement properties of each PRO. RESULTS: Twenty studies were included. Nine different questionnaires for patients with hip disability, and one for hip and groin disability, were identified. Hip And Groin Outcome Score (HAGOS), Hip Outcome Score (HOS), International Hip Outcome Tool-12 (IHOT-12) and IHOT-33 were the most thoroughly investigated PROs and studies including these PROs reported key aspects of the COSMIN checklist. HAGOS and IHOT-12 were based on studies with the least ratings of poor study methodology (23% and 31%, respectively), whereas IHOT-33 and HOS had a somewhat larger distribution (46%). These PROs all contain adequate measurement qualities for content validity (except HOS), test-retest reliability, construct validity, responsiveness and interpretability. No information or poor quality rating on methodological aspects made it impossible to fully evaluate the remaining PROs at present. CONCLUSIONS: HAGOS, HOS, IHOT-12 and IHOT-33 can be recommended for assessment of young-aged to middle-aged adults with pain related to the hip joint, undergoing non-surgical treatment or hip arthroscopy. At present, HAGOS is the only PRO also aimed for young-aged to middle-aged adults presenting with groin pain and is recommended for use in this population. TRIAL REGISTRATION NUMBER: CRD42014009995. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
Entities:
Keywords:
Evidence based review; Groin; Hip; Orthopaedics; Sports medicine
Authors: Eamonn Delahunt; Kristian Thorborg; Karim M Khan; Philip Robinson; Per Hölmich; Adam Weir Journal: Br J Sports Med Date: 2015-06 Impact factor: 13.800
Authors: Adam Weir; Peter Brukner; Eamonn Delahunt; Jan Ekstrand; Damian Griffin; Karim M Khan; Greg Lovell; William C Meyers; Ulrike Muschaweck; John Orchard; Hannu Paajanen; Marc Philippon; Gilles Reboul; Philip Robinson; Anthony G Schache; Ernest Schilders; Andreas Serner; Holly Silvers; Kristian Thorborg; Timothy Tyler; Geoffrey Verrall; Robert-Jan de Vos; Zarko Vuckovic; Per Hölmich Journal: Br J Sports Med Date: 2015-06 Impact factor: 13.800
Authors: J J Heerey; R Srinivasan; R Agricola; A Smith; J L Kemp; T Pizzari; M G King; P R Lawrenson; M J Scholes; R B Souza; T Link; S Majumdar; K M Crossley Journal: Osteoarthritis Cartilage Date: 2020-12-30 Impact factor: 6.576
Authors: M Tijssen; R E H van Cingel; J B Staal; S Teerenstra; E de Visser; M W G Nijhuis-van der Sanden Journal: Trials Date: 2016-02-17 Impact factor: 2.279